The implementation of a self-inspection program was inadequate.
Inspection Record
LEC Custom Products Inc. — Health Canada Inspection Findings
View the regulator's official source The source document is always the basis for judgement.
Findings
The temperature and/or humidity control was inadequate.
The preventative maintenance program was inadequate for the equipment used in significant processing and/or testing operations.
The quality control department did not evaluate the results of the annual product quality review.
The availability, content and/or maintenance of the quality agreements between the supplier, fabricator, tester, packager, labeller, distributor, importer, and/or wholesaler was inadequate.
The investigation, handling, and/or reporting of test results that were out-of-specification was inadequate.
The change control system was inadequate for ensuring changes are properly documented, evaluated, and/or approved.
The creation, maintenance, processing, and/or review of laboratory data was inadequate.
The written procedures for recalls were inadequate.
Senior management's ability to determine and/or provide adequate and/or appropriate resources to implement, maintain and/or improve the effectiveness of the quality management system was inadequate. The quality control department did not undertake all of the required activities.
The company did not determine the stability of the drug before it was marketed or before significant changes were made to the drug formulations, fabrication procedures, or packaging materials.
The implementation and/or the effectiveness of the sanitation program in preventing unsanitary conditions was inadequate. The sanitation programs were not adequately designed to identify and/or reduce the risks of contamination. The sanitation program was inadequate in its cleaning procedures, frequency of cleaning, procedures for waste disposal, and/or pest control measures.
The premises were not designed, constructed, operated, and/or maintained to allow clean and orderly conditions.
Investigations into deviations, reports, and/or follow-up actions were inadequate.
The written specifications were inadequate. The availability or the content of the authentic certificate of analysis was inadequate. Lots or batches of finished product were not examined or tested against the specifications before they were fabricated or sold.
Evaluation of production processes, equipment, and/or materials was inadequate. The master production documents were inadequate.
The job descriptions for personnel, the authority given to personnel, and/or the delegation of duties was inadequate and/or undocumented.
About this record
Extracted automatically from the document of the Health Canada inspection on 2023-07-31. The source is available at the link above.
This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.
Translation and classification are automated and may differ in nuance from the source.
